236 related articles for article (PubMed ID: 24027305)
21. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous generation of infectious prion disease in transgenic mice.
Torres JM; Castilla J; Pintado B; Gutiérrez-Adan A; Andréoletti O; Aguilar-Calvo P; Arroba AI; Parra-Arrondo B; Ferrer I; Manzanares J; Espinosa JC
Emerg Infect Dis; 2013 Dec; 19(12):1938-47. PubMed ID: 24274622
[TBL] [Abstract][Full Text] [Related]
23. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.
Manuelidis L; Liu Y; Mullins B
J Cell Biochem; 2009 Feb; 106(2):220-31. PubMed ID: 19097123
[TBL] [Abstract][Full Text] [Related]
24. Porcine prion protein amyloid.
Hammarström P; Nyström S
Prion; 2015; 9(4):266-77. PubMed ID: 26218890
[TBL] [Abstract][Full Text] [Related]
25.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
26. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
27. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
28. A domain responsible for spontaneous conversion of bank vole prion protein.
Kobayashi A; Matsuura Y; Takeuchi A; Yamada M; Miyoshi I; Mohri S; Kitamoto T
Brain Pathol; 2019 Mar; 29(2):155-163. PubMed ID: 30051525
[TBL] [Abstract][Full Text] [Related]
29. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
30. Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.
Takeuchi A; Kobayashi A; Ironside JW; Mohri S; Kitamoto T
J Biol Chem; 2013 Jul; 288(30):21659-66. PubMed ID: 23792955
[TBL] [Abstract][Full Text] [Related]
31. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
32. Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases.
Jackson WS; Borkowski AW; Watson NE; King OD; Faas H; Jasanoff A; Lindquist S
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14759-64. PubMed ID: 23959875
[TBL] [Abstract][Full Text] [Related]
33. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
34. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
[TBL] [Abstract][Full Text] [Related]
35. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.
Sigurdson CJ; Nilsson KP; Hornemann S; Heikenwalder M; Manco G; Schwarz P; Ott D; Rülicke T; Liberski PP; Julius C; Falsig J; Stitz L; Wüthrich K; Aguzzi A
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):304-9. PubMed ID: 19073920
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
37. Prion disease: a deadly disease for protein misfolding.
Chakraborty C; Nandi S; Jana S
Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
[TBL] [Abstract][Full Text] [Related]
38. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
39. A kinetic model for amyloid formation in the prion diseases: importance of seeding.
Come JH; Fraser PE; Lansbury PT
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5959-63. PubMed ID: 8327467
[TBL] [Abstract][Full Text] [Related]
40. Prion protein and species barriers in the transmissible spongiform encephalopathies.
Priola SA
Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
